Plant Comparison
Perforate St John’s-wort vs Common Sorrel
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Perforate St John’s-wort and Common Sorrel: they share 5 indicated uses (arthritis / joint pain, infection (general), inflammation (general), …); 2 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Perforate St John’s-wort | Common Sorrel | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 1/10 | Comparable evidence |
| Infection (general) | 1/10 | 2/10 | Comparable evidence |
| Inflammation (general) | 1/10 | 2/10 | Comparable evidence |
| Skin irritation | 1/10 | 1/10 | Comparable evidence |
| Wounds | 1/10 | 1/10 | Comparable evidence |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Red pigments historically used to standardise extracts; contribute to antiviral activity and are the compounds responsible for photosensitivity risk.
Considered the principal compound behind the antidepressant activity and the main driver of the herb's potent CYP3A4/P-glycoprotein induction and drug-interaction profile.
Antioxidant flavonoids contributing to overall activity.
Gives the leaf its characteristic sour taste; the basis for the caution around kidney stones and mineral absorption at high intakes.
Minor constituents typical of the Rumex genus, studied alongside other isolated compounds for antibacterial activity against Helicobacter pylori.
The basis for the plant's traditional antiscorbutic (anti-scurvy) reputation.
Pharmacological Actions
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from antiviral action
inferred from anti-inflammatory action
inferred from sedative action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from digestive action
inferred from antimicrobial action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from diuretic action
inferred from diuretic action
inferred from diuretic action
Safety, Cautions & Contraindications
Significant drug interactions: strongly induces CYP3A4 and P-glycoprotein, reducing plasma levels of many drugs including oral contraceptives, antiretrovirals, cyclosporine, warfarin, and digoxin. May cause photosensitivity (fair-skinned individuals). Do not combine with SSRIs, SNRIs, or MAOIs (serotonin syndrome risk). Avoid in bipolar disorder.
Duke (2002) rates St. John's wort as ++ (raised from earlier editions) and notes antidepressant, antiviral, antibacterial, and wound-healing activities at experimental and clinical levels. Hypericin and hyperforin are identified as key active constituents. Clinical evidence (score 2) confirms antidepressant efficacy in mild-to-moderate depression, and WHO/Commission E provide approval for this indication. Dose: 300 mg standardized extract (0.3% hypericin, 3–5% hyperforin) three times daily. Duke emphasizes the critical drug interaction: St. John's wort is a potent CYP3A4 inducer and can significantly reduce blood levels of many medications including oral contraceptives, cyclosporine, antiretrovirals, and warfarin. Avoid combined use with SSRIs (serotonin syndrome risk) and pharmaceutical antidepressants (Duke, 2002).
High in oxalates (the sour taste): Large, frequent amounts can be a bad idea if you’re prone to kidney or bladder stones, or certain “rheumatic-type” complaints (Royal Botanic Gardens, Kew, n.d.). Moderation matters: Measured oxalate levels in leaves can be high, and researchers recommend treating sorrel more like an occasional delicacy than a daily staple (Tuazon-Nartea & Savage, 2013). Mineral binding: Oxalic acid can reduce how much calcium you absorb from a meal (Tuazon-Nartea & Savage, 2013). Sensitive stomach/mouth: Very sour leaves can irritate some people (common-sense caution; strongest source is the oxalate discussion above). Pregnancy/lactation: As a normal food herb in culinary amounts is generally considered fine, but avoid high-dose “medicinal” use because safety data are limited (Bello et al., 2019). Foraging safety (important): Sorrel can accumulate heavy metals depending on where it grows; avoid harvesting near roads/industrial areas (Gawęda, 2009).
Duke (2002) rates sorrel as ++ and notes diuretic, antiscorbutic (high vitamin C), and depurative activities at experimental and folkloric levels. The plant is traditionally used for anemia, fever, and scurvy prevention. High oxalic acid content is an important consideration — excessive consumption can promote kidney stone formation (oxalate stones) and may be harmful in individuals with gout or existing kidney disease. Duke advises limiting medicinal use and avoiding in those with a history of calcium oxalate kidney stones (Duke, 2002).
External Ids
Botanical Description
Erect, branching perennial herb with paired, oval leaves dotted with tiny translucent oil glands that look like pinpricks when held to the light (giving the species name 'perforatum'). Bright yellow, five-petalled flowers with numerous stamens and black dots along the petal edges are borne in flat-topped clusters, and release a reddish pigment when crushed.[4]
Perennial herb (Polygonaceae), 30-100 cm tall, with erect, often reddish, ridged flowering stems. Basal leaves are arrow- (hastate-) shaped with backward-pointing basal lobes, and sour-tasting from oxalic acid content. Tiny reddish-brown flowers are borne in narrow, branched spikes; the species is dioecious, with separate male and female plants.[11]
Habitat
Grows in grassland, roadsides, woodland clearings and waste ground on well-drained soils; native to Europe, Western Asia and North Africa and widely naturalised elsewhere, including North America and Australia.[4]
Native throughout Europe and temperate Asia, common in meadows, grassland, pastures and roadside verges on a wide range of soils, tolerating both damp and dry ground.[11]
Harvesting
The flowering tops (flower and upper leaf) are cut in summer as the flowers open, around the traditional St John's Day period, and dried quickly in a warm, shaded, airy place to preserve the hypericin and hyperforin content.[4]
Leaves are gathered fresh in spring and early summer, before flowering, when they are most tender and least bitter. Avoid harvesting near roads or industrial areas, given the plant's tendency to accumulate heavy metals.[11]
Traditional Uses
St John's wort has a centuries-long European folk reputation as a wound-healing and nerve tonic herb, traditionally used for mild wounds, burns and nerve pain and to lift low mood; this traditional mood-supporting use is now one of the most extensively clinically studied applications of any herbal medicine, with standardised extracts shown comparable to conventional antidepressants for mild-to-moderate depression.[1, 4]
Common sorrel has a long European culinary-medicinal tradition as a refreshing, vitamin-C-rich spring green and digestive bitter, and folk-medicinally as a diuretic and mild antiscorbutic (anti-scurvy) remedy. Modern research confirms antioxidant, anti-inflammatory and antimicrobial activity of its leaf extracts.[11]
Preparations
Flowering-top extract standardised to hypericin and/or hyperforin content, taken as tablets or capsules; the best-studied clinical form for mood support.
Dosage
Clinical trials for mild-to-moderate depression commonly use around 300 mg of standardised extract three times daily (900 mg/day total); given extensive drug interactions, use should be discussed with a healthcare provider, especially alongside other medicines. Educational reference only, not a prescription.
Sorrel is best treated as an occasional food rather than a daily medicinal herb, given its oxalate content; traditional infusions use roughly 2-4 g dried leaf per cup, taken occasionally rather than regularly. Educational reference only, not a prescription; avoid large or frequent amounts if prone to kidney stones or gout.
Drug Class Interactions
Not documented
References
Pairings
St John's wort raises serotonin activity and can cause serotonin syndrome when combined with other serotonin-boosting agents; pairing it with another mood-active, serotonergic herb such as saffron may add to this risk.[30]
St John's wort is a strong enzyme inducer and increases serotonin activity; combining it with another antidepressant-type herb such as rhodiola may add to serotonergic effects and unpredictably change how each is handled by the body.[30]
St John's wort speeds up the breakdown of many substances and also raises serotonin activity; pairing it with a sedative herb such as valerian may add to drowsiness and can unpredictably change how each is handled by the body.[30, 31]
St John's wort is a strong enzyme inducer and kava is a liver-metabolised sedative; combining them may add to central-nervous-system effects and alter how kava is processed, so combined use warrants caution.[30, 31]
Not documented
Lookalikes Review
Dangerous Lookalikes
Not documented
References & Sources
- Ng, Q.X., Venkatanarayanan, N. and Ho, C.Y.X (2017) 'Clinical use of Hypericum perforatum (St John's wort) in depression: A meta-analysis', Journal of Affective Disorders, 210, pp. 211-221. doi:10.1016/j.jad.2016.12.048 Meta-analysis / review
https://doi.org/10.1016/j.jad.2016.12.048 - Kholghi, G., Arjmandi-Rad, S., Zarrindast, M.R. and Vaseghi, S (2022) 'St. John's wort (Hypericum perforatum) and depression: what happens to the neurotransmitter systems?', Naunyn-Schmiedeberg's Archives of Pharmacology, 395(6), pp. 629-642. doi:10.1007/s00210-022-02229-z Traditional / reference
https://doi.org/10.1007/s00210-022-02229-z - Fugh-Berman, A (2000) 'Herb-drug interactions', Lancet, 355(9198), pp. 134-138. doi:10.1016/S0140-6736(99)06457-0 Traditional / reference
https://doi.org/10.1016/S0140-6736(99)06457-0 - Nobakht, S.Z., Akaberi, M., Mohammadpour, A.H., Tafazoli Moghadam, A. and Emami, S.A (2022) 'Hypericum perforatum: Traditional uses, clinical trials, and drug interactions', Iranian Journal of Basic Medical Sciences, 25(9), pp. 1045-1058. doi:10.22038/IJBMS.2022.65112.14338 Meta-analysis / review
https://doi.org/10.22038/IJBMS.2022.65112.14338 - Jiang, Z., Wang, F., Zhao, Y., Lu, L., Jiang, X., Huang, T., Lin, Y., Guo, L., Weng, Z. and Liu, E (2024) 'Hypericum perforatum L. attenuates depression by regulating Akkermansia muciniphila, tryptophan metabolism and NFkB-NLRP2-Caspase1-IL1beta pathway', Phytomedicine, 132, pp. 155847. doi:10.1016/j.phymed.2024.155847 Preclinical
https://doi.org/10.1016/j.phymed.2024.155847 - Oliveira, A.I., Pinho, C., Sarmento, B. and Dias, A.C.P (2016) 'Neuroprotective Activity of Hypericum perforatum and Its Major Components', Frontiers in Plant Science, 7, pp. 1004. doi:10.3389/fpls.2016.01004 Meta-analysis / review
https://doi.org/10.3389/fpls.2016.01004 - Russo, E., Scicchitano, F., Whalley, B.J., Mazzitello, C., Ciriaco, M., Esposito, S., Patane, M., Upton, R., Pugliese, M., Chimirri, S., Mammi, M., Palleria, C. and De Sarro, G (2013) 'Hypericum perforatum: pharmacokinetic, mechanism of action, tolerability, and clinical drug-drug interactions', Phytotherapy Research, 28(5), pp. 643-655. doi:10.1002/ptr.5050 Meta-analysis / review
https://doi.org/10.1002/ptr.5050 - Saddiqe, Z., Naeem, I. and Maimoona, A (2010) 'A review of the antibacterial activity of Hypericum perforatum L', Journal of Ethnopharmacology, 131(3), pp. 511-521. doi:10.1016/j.jep.2010.07.034 Meta-analysis / review
https://doi.org/10.1016/j.jep.2010.07.034 - Mennini, T. and Gobbi, M (2004) 'The antidepressant mechanism of Hypericum perforatum', Life Sciences, 75(9), pp. 1021-1027. doi:10.1016/j.lfs.2004.04.005 Meta-analysis / review
https://doi.org/10.1016/j.lfs.2004.04.005 - Liu, Y., Jiang, Y., Huang, R., Yang, J., Xiao, B. and Dong, J (2013) 'Hypericum perforatum L. preparations for menopause: a meta-analysis of efficacy and safety', Climacteric, 17(4), pp. 325-335. doi:10.3109/13697137.2013.861814 Meta-analysis / review
https://doi.org/10.3109/13697137.2013.861814 - Wurglics, M. and Schubert-Zsilavecz, M (2006) 'Hypericum perforatum: a 'modern' herbal antidepressant: pharmacokinetics of active ingredients', Clinical Pharmacokinetics, 45(5), pp. 449-468. doi:10.2165/00003088-200645050-00002 Meta-analysis / review
https://doi.org/10.2165/00003088-200645050-00002 - Kasper, S (2001) 'Hypericum perforatum - a review of clinical studies', Pharmacopsychiatry, 34(Suppl 1), pp. S51-S55. doi:10.1055/s-2001-15467 Meta-analysis / review
https://doi.org/10.1055/s-2001-15467 - Nathan, P (1999) 'The experimental and clinical pharmacology of St John's Wort (Hypericum perforatum L.)', Molecular Psychiatry, 4(4), pp. 333-338. doi:10.1038/sj.mp.4000557 Meta-analysis / review
https://doi.org/10.1038/sj.mp.4000557 - Verotta, L (2003) 'Hypericum perforatum, a source of neuroactive lead structures', Current Topics in Medicinal Chemistry, 3(2), pp. 187-201. doi:10.2174/1568026033392589 Meta-analysis / review
https://doi.org/10.2174/1568026033392589 - Linde, K. et al (2008) 'St John'. Traditional / reference
https://scholar.google.com/scholar?q=St%20John - Natural Standard (2013) 'Hypericum perforatum (St'. Traditional / reference
https://scholar.google.com/scholar?q=Hypericum%20perforatum%20%28St - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Zhou, S., Chan, E., Pan, S.Q., Huang, M. and Lee, E.J.D (2004) 'Pharmacokinetic interactions of drugs with St John's wort', Journal of Psychopharmacology, 18(2), pp. 262-276. doi:10.1177/0269881104042632 Meta-analysis / review
https://doi.org/10.1177/0269881104042632 - Izzo, A.A. and Ernst, E (2009) 'Interactions between herbal medicines and prescribed drugs: an updated systematic review', Drugs, 69(13), pp. 1777-1798. doi:10.2165/11317010-000000000-00000 Meta-analysis / review
https://doi.org/10.2165/11317010-000000000-00000 - Borrelli, F. and Izzo, A.A (2009) 'Herb-drug interactions with St John's wort (Hypericum perforatum): an update on clinical observations', The AAPS Journal, 11(4), pp. 710-727. doi:10.1208/s12248-009-9146-8 Meta-analysis / review
https://doi.org/10.1208/s12248-009-9146-8 - Nicolussi, S., Drewe, J., Butterweck, V. and Meyer zu Schwabedissen, H.E (2020) 'Clinical relevance of St. John's wort drug interactions revisited', British Journal of Pharmacology, 177(6), pp. 1212-1226. doi:10.1111/bph.14936 Meta-analysis / review
https://doi.org/10.1111/bph.14936 - Piscitelli, S.C., Burstein, A.H., Chaitt, D., Alfaro, R.M. and Falloon, J (2000) 'Indinavir concentrations and St John's wort', Lancet, 355(9203), pp. 547-548. doi:10.1016/S0140-6736(99)05712-8 Clinical study
https://doi.org/10.1016/S0140-6736(99)05712-8 - Barone, G.W., Gurley, B.J., Ketel, B.L., Lightfoot, M.L. and Abul-Ezz, S.R (2000) 'Drug interaction between St. John's wort and cyclosporine', Annals of Pharmacotherapy, 34(9), pp. 1013-1016. doi:10.1345/aph.10088 Clinical study
https://doi.org/10.1345/aph.10088 - Murphy, P.A., Kern, S.E., Stanczyk, F.Z. and Westhoff, C.L (2005) 'Interaction of St. John's Wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding', Contraception, 71(6), pp. 402-408. doi:10.1016/j.contraception.2004.11.004 Clinical study
https://doi.org/10.1016/j.contraception.2004.11.004 - Murphy, P.A., Kern, S.E., Stanczyk, F.Z. and Westhoff, C.L (2005) 'Interaction of St. John's Wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding', Contraception, 71(6), pp. 402-408. doi:10.1016/j.contraception.2004.11.004 Clinical study
https://doi.org/10.1016/j.contraception.2004.11.004 - Pfrunder, A., Schiesser, M., Gerber, S., Haschke, M., Bitzer, J. and Drewe, J (2003) 'Interaction of St John's wort with low-dose oral contraceptive therapy: a randomized controlled trial', British Journal of Clinical Pharmacology, 56(6), pp. 683-690. doi:10.1046/j.1365-2125.2003.02005.x Randomized trial
https://doi.org/10.1046/j.1365-2125.2003.02005.x - Johne, A., Brockmoller, J., Bauer, S., Maurer, A., Langheinrich, M. and Roots, I (1999) 'Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum)', Clinical Pharmacology and Therapeutics, 66(4), pp. 338-345. doi:10.1053/cp.1999.v66.a101944 Clinical study
https://doi.org/10.1053/cp.1999.v66.a101944 - Mathijssen, R.H.J., Verweij, J., de Bruijn, P., Loos, W.J. and Sparreboom, A (2002) 'Effects of St. John's wort on irinotecan metabolism', Journal of the National Cancer Institute, 94(16), pp. 1247-1249. doi:10.1093/jnci/94.16.1247 Randomized trial
https://doi.org/10.1093/jnci/94.16.1247 - Smith, P., Bullock, J.M., Booker, B.M., Haas, C.E., Berenson, C.S. and Jusko, W.J (2004) 'The influence of St. John's wort on the pharmacokinetics and protein binding of imatinib mesylate', Pharmacotherapy, 24(11), pp. 1508-1514. doi:10.1592/phco.24.16.1508.50958 Clinical study
https://doi.org/10.1592/phco.24.16.1508.50958 - Izzo, A.A (2004) 'Drug interactions with St. John's Wort (Hypericum perforatum): a review of the clinical evidence', International Journal of Clinical Pharmacology and Therapeutics, 42(3), pp. 139-148. doi:10.5414/cpp42139 Meta-analysis / review
https://doi.org/10.5414/cpp42139 - Caus, M.N., Lupoae, M. and Chitescu, C.L (2026) 'Efficacy and Safety of Herbal Supplements with Anxiolytic, Antidepressant, and Sedative Action: A Review of Clinical Data and Toxicological Risks', Pharmaceuticals, 19(3), pp. 399. doi:10.3390/ph19030399 Meta-analysis / review
https://doi.org/10.3390/ph19030399
- Jeong, D., Irfan, M., Kim, S.D., Kim, S. and others (2020) 'Rumex acetosa modulates platelet function and inhibits thrombus formation in rats', BMC Complementary Medicine and Therapies, 20(1), pp. 98. doi:10.1186/s12906-020-02889-5 Preclinical
https://doi.org/10.1186/s12906-020-02889-5 - Oh, D.R., Kim, Y., Choi, E.J., Jung, M.A. and others (2025) 'Rumex acetosa L. enhances learning and cognitive function by modulating NMDA receptor and BDNF pathways in vitro and in vivo', Metabolic Brain Disease, 40(5), pp. 185. doi:10.1007/s11011-025-01608-8 Preclinical
https://doi.org/10.1007/s11011-025-01608-8 - Kang, Y.M., Lee, K.Y., An, H.J. and others (2023) 'Anti-Helicobacter pylori Activity of Six Major Compounds Isolated from Rumex acetosa', ACS Omega, 8(45), pp. 42548-42554. doi:10.1021/acsomega.3c05282 Preclinical
https://doi.org/10.1021/acsomega.3c05282 - Sun, Y.Y., Su, X.H., Jin, J.Y., Zhou, J. and others (2015) 'Rumex acetosa L. induces vasorelaxation in rat aorta via activation of PI3-kinase/Akt- and Ca2+-eNOS-NO signaling in endothelial cells', Journal of Physiology and Pharmacology, 66(6), pp. 907-915. Available at: https://pubmed.ncbi.nlm.nih.gov/26769840/ Preclinical
https://pubmed.ncbi.nlm.nih.gov/26769840/ - Selbach, S., Klocke, A., Peters, U., Beckert, S. and others (2021) 'Microbiological and Clinical Effects of a Proanthocyanidin-enriched Extract from Rumex acetosa in Periodontally Healthy Carriers of Porphyromonas gingivalis: a Randomized Controlled Pilot Study', Planta Medica, 89(11), pp. 1052-1062. doi:10.1055/a-1728-2249 Randomized trial
https://doi.org/10.1055/a-1728-2249 - Ahn, S.H., Jeon, J.H., Kim, H.J., Maeng, H.J. and others (2020) 'Effect of Rumex acetosa Extract, a Herbal Drug, on the Absorption of Fexofenadine', Pharmaceutics, 12(6), pp. 547. doi:10.3390/pharmaceutics12060547 Preclinical
https://doi.org/10.3390/pharmaceutics12060547 - Feduraev, P., Skrypnik, L., Nebreeva, S., Dzhobadze, G. and others (2022) 'Variability of Phenolic Compound Accumulation and Antioxidant Activity in Wild Plants of Some Rumex Species (Polygonaceae)', Antioxidants (Basel), 11(2), pp. 311. doi:10.3390/antiox11020311 Preclinical
https://doi.org/10.3390/antiox11020311 - Li, J.J., Li, Y.X., Li, N., Zhu, H.T. and others (2022) 'The genus Rumex (Polygonaceae): an ethnobotanical, phytochemical and pharmacological review', Natural Products and Bioprospecting, 12(1), pp. 21. doi:10.1007/s13659-022-00346-z Traditional / reference
https://doi.org/10.1007/s13659-022-00346-z - Prakash Mishra, A., Sharifi-Rad, M., Shariati, M.A., Mabkhot, Y.N. and others (2018) 'Bioactive compounds and health benefits of edible Rumex species - A review', Cellular and Molecular Biology, 64(8), pp. 27-34. doi:10.14715/cmb/2018.64.8.5 Traditional / reference
https://doi.org/10.14715/cmb/2018.64.8.5 - Pan, Y., Zhao, X., Kim, S.H., Kang, S.A. and others (2020) 'Anti-inflammatory effects of Beopje curly dock (Rumex crispus L.) in LPS-induced RAW 264.7 cells and its active compounds', Journal of Food Biochemistry, 44(7), pp. e13291. doi:10.1111/jfbc.13291 Preclinical
https://doi.org/10.1111/jfbc.13291 - Chevallier, A (1996) 'The Encyclopedia of Medicinal Plants'. Traditional / reference
https://scholar.google.com/scholar?q=The%20Encyclopedia%20of%20Medicinal%20Plants - Grieve, M (1931) 'A Modern Herbal'. Traditional / reference
https://scholar.google.com/scholar?q=A%20Modern%20Herbal - Royal Botanic Gardens, Kew (n.d.). Available at: https://powo.science.kew.org Traditional / reference
https://powo.science.kew.org - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Foraging Course Company 'Foraging Guide: Lords and Ladies (Arum maculatum)'. Available at: https://www.foragingcoursecompany.co.uk/post/foraging-guide-lords-and-ladies Traditional / reference
https://www.foragingcoursecompany.co.uk/post/foraging-guide-lords-and-ladies - Wild Food UK (2020) 'Wild garlic impostors'. Available at: https://www.wildfooduk.com/articles/identifying-mushrooms-and-plants/wild-garlic-impostors/ Traditional / reference
https://www.wildfooduk.com/articles/identifying-mushrooms-and-plants/wild-garlic-impostors/
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.